ABSTRACT
In response to the emergency management caused by COVID-19, Taiwan began to impose a name-based rationing system for the purchase of face masks by having consumers visit physical stores and preorder them online. By doing so, the risk of face mask shortages caused by panic buying was reduced. To understand consumers' willingness to switch from buying face masks at physical stores to preordering them online, we used a push-pull-mooring (PPM) model to measure related dimensions. We administered an online questionnaire survey and collected 233 valid responses. In the present study, perceived risk (including time risk, psychological risk and social risk) was treated as a second-order formative indicator, while pull effect was measured by the variables of critical mass and alternative attraction. Mooring effect was measured by switching cost. Through structural equation modeling (SEM), perceived risk, as well as critical mass and alternative attraction, had a significant effect on switching intention, while switching cost had no significant relationship with switching intention. This study investigated whether perceived risk (time risk, psychological risk and social risk), critical mass, alternative attraction and switching cost can serve as references for purchase behaviors amid future emergency management, through the prism of population migration theory, and proposed recommendations for their promotion and implementation.
ABSTRACT
The pandemic of coronavirus disease 2019 (COVID-19) caused by the SARS-coronavirus 2(SARS-CoV-2) virus has become the greatest global public health crisis in recent years,and the COVID-19 epidemic is still continuing. However, due to the lack of effectivetherapeutic drugs, the treatment of corona viruses is facing huge challenges. In thiscontext, countries with a tradition of using herbal medicine such as China have beenwidely using herbal medicine for prevention and nonspecific treatment of corona virusesand achieved good responses. In this review, we will introduce the application of herbalmedicine in the treatment of corona virus patients in China and other countries, andreview the progress of related molecular mechanisms and antiviral activity ingredients ofherbal medicine, in order to provide a reference for herbal medicine in the treatment ofcorona viruses. We found that herbal medicines are used in the prevention and fightagainst COVID-19 in countries on all continents. In China, herbal medicine has beenreported to relieve some of the clinical symptoms of mild patients and shorten the length of hospital stay. However, as most herbal medicines for the clinical treatment of COVID-19still lack rigorous clinical trials, the clinical and economic value of herbal medicines in theprevention and treatment of COVID-19 has not been fully evaluated. Future work basedon large-scale randomized, double-blind clinical trials to evaluate herbal medicines andtheir active ingredients in the treatment of new COVID-19 will be very meaningful.